T1	Participants 57 95	locally advanced nasopharyngeal cancer
T2	Participants 152 165	single centre
T3	Participants 333 398	patients with locoregionally advanced nasopharyngeal cancer (NPC)
T4	Participants 421 494	From August 1999 to December 2004, 206 patients with locally advanced NPC
T5	Participants 1730 1761	locoregional advanced stage NPC
